Shuailin Li

Oxford, ENG OX37DQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Journal: Cell reports. Medicine
Published: February 11, 2026

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Journal: Frontiers in immunology
Published: February 09, 2026

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

Journal: iScience
Published: September 08, 2025

MetE: a promising protective antigen for tuberculosis vaccine development.

MetE: a promising protective antigen for tuberculosis vaccine development.

Journal: Frontiers in immunology
Published: March 13, 2025

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Journal: Frontiers in immunology
Published: December 05, 2024

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Journal: Scientific reports
Published: September 24, 2024

MAIT cells protect against sterile lung injury.

MAIT cells protect against sterile lung injury.

Journal: Cell reports
Published: September 12, 2024

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Journal: Nature communications
Published: August 01, 2024

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.

Journal: NPJ vaccines
Published: July 04, 2024

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.

Journal: Vaccine
Published: May 15, 2024

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates.

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates.

Journal: Frontiers in immunology
Published: February 17, 2024

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants.

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants.

Journal: Nature communications
Published: May 07, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026